Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient Controlled Methylphenidate for Cancer Related Fatigue
NCT05041946Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2003
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate hydrochloride extended-release chewable tablet in cancer-related fatigue (CRF), sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2003; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT05041946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05041946.